PDS Biotechnology Corporation (NASDAQ:PDSB)’s traded shares stood at 1.13 million during the last session, with the company’s beta value hitting 1.80. At the close of trading, the stock’s price was $2.90, to imply an increase of 6.62% or $0.18 in intraday trading. The PDSB share’s 52-week high remains $10.27, putting it -254.14% down since that peak but still an impressive 7.59% since price per share fell to its 52-week low of $2.68. The company has a valuation of $106.37M, with an average of 923.76K shares over the past 3 months.

PDS Biotechnology Corporation (NASDAQ:PDSB) trade information

After registering a 6.62% upside in the last session, PDS Biotechnology Corporation (PDSB) has traded red over the past five days. The stock hit a weekly high of 3.38, jumping 6.62% in its intraday price action. The 5-day price performance for the stock is -13.95%, and -38.17% over 30 days. With these gigs, the year-to-date price performance is -41.65%.

PDS Biotechnology Corporation (PDSB) estimates and forecasts

Looking at statistics comparing PDS Biotechnology Corporation share performance against respective industry, we note that the company has underperformed competitors. PDS Biotechnology Corporation (PDSB) shares are -36.96% down over the last 6 months, with its year-to-date growth rate lower than industry average at -11.51% against 13.10%.

PDSB Dividends

PDS Biotechnology Corporation has its next earnings report out between May 13 and May 17. However, it is important to take into account that this dividend yield ratio is just an indicator to only serve the purpose of guidance. Investors interested to invest in the stock should ponder company’s other fundamental and operations related aspects too. PDS Biotechnology Corporation has a forward dividend ratio of 0, with the share yield ticking at 0.00% to continue the rising pattern observed over the past year. The company’s average dividend yield trailing the past 5-year period is 0.00%.